Eutectic Lidocaine Prilocaine for Contraception

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
Contraception
Eutectic Lidocaine Prilocaine - Drug
Eligibility
18+
Female
What conditions do you have?
Select

Study Summary

This trial is testing whether EMLA cream is more effective than lidocaine for pain during and time to removal of Nexplanon.

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Study Objectives

2 Primary · 2 Secondary · Reporting Duration: procedure

during procedure
pain of procedure
procedure
How likely to recommend their anesthetic?
Provider's sense of ease of removal?
time to perform procedure

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Trial Design

2 Treatment Groups

Subcutaneous Lidocaine
1 of 2
EMLA
1 of 2
Active Control
Experimental Treatment

40 Total Participants · 2 Treatment Groups

Primary Treatment: Eutectic Lidocaine Prilocaine · No Placebo Group · Phase 4

EMLA
Drug
Experimental Group · 1 Intervention: Eutectic Lidocaine Prilocaine · Intervention Types: Drug
Subcutaneous Lidocaine
Drug
ActiveComparator Group · 1 Intervention: Subcutaneous Lidocaine · Intervention Types: Drug

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: procedure

Who is running the clinical trial?

Augusta UniversityLead Sponsor
192 Previous Clinical Trials
74,081 Total Patients Enrolled

Eligibility Criteria

Age 18+ · Female Participants · 1 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 22nd, 2021

Last Reviewed: October 27th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.

Who else is applying?

How old are they?
18 - 65100.0%
What site did they apply to?
Augusta University Ob/Gyn Resident Continuity Clinic100.0%
What portion of applicants met pre-screening criteria?
Met criteria100.0%